Managing Oral Anti-Cancer Medications

Nov 10, 2020

As the number of oral anti-cancer medications continues to grow, so do new challenges in education, care delivery, and patient adherence to treatment. Additionally, dispensing requirements from manufacturers, payers, and regulators continue to change as healthcare transitions to a value-based care environment.

On this episode of CANCER BUZZ, learn about the role of the interdisciplinary cancer team in managing oral chemotherapy for patients with cancer. Discover how one cancer program has transformed their care model, improving their workflow while keeping the patient at the center of the process.

Guests:

• Marnee Lieberman, CPhT, Oncology Liaison, Masonic Cancer Center
• Jeff Engle, PharmD, MS, Hematology/Oncology Clinical Pharmacist, Fairview Specialty Pharmacy & Masonic Cancer Center

Related Content:

• Evaluating Pharmacy Dispensing Models to Help Improve Cancer Care Delivery
• Oral Chemotherapy Education Sheets
• The Role of the Oral Oncology Nurse Navigator, by Mark K. Anderson, BSN, RN, OCN, et al.
• Oral Oncolytic Welcome Letter, National Community Oncology Dispensing Association, Inc.
• Mini-Podcast: COVID-19 & Oral Oncolytics

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.